119th Congress · introduced in the House · Jul 10, 2025
To reauthorize the Kay Hagan Tick Act, and for other purposes.
Official title from Congress.gov
Latest action (Jul 21, 2026): Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Reported to House (Jul 2, 2026)
This bill reauthorizes through FY2030 activities of the Centers for Disease Control and Prevention to address vector-borne diseases (e.g., diseases spread by bites from ticks or mosquitoes). These activities include (1) a national strategy, (2) grants for regional centers of excellence, and (3) cooperative agreements with state, local, and tribal health departments to increase capacity for preventing and responding to vector-borne diseases.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4640)
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4640)
DEBATE - The House proceeded with forty minutes of debate on H.R. 4348.
Considered under suspension of the rules. (consideration: CR H4640-4642)
Mr. Guthrie moved to suspend the rules and pass the bill.
Placed on the Union Calendar, Calendar No. 630.
Reported by the Committee on Energy and Commerce. H. Rept. 119-725.
Reported by the Committee on Energy and Commerce. H. Rept. 119-725.
Ordered to be Reported by the Yeas and Nays: 48 - 0.
Committee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee by Voice Vote.
Subcommittee Consideration and Mark-up Session Held
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Introduced in House
Health programs administration and funding · Infectious and parasitic diseases
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsIntroduced in House
Actions from Congress.gov, newest first.
Coverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
2 citations.
ENTOMOLOGICAL SOCIETY OF AMERICA · lobbying firm or registrant: LEWIS-BURKE ASSOCIATES, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 15, 2026 · issue area: Health Issues
$30,000
Paid to lobbying firm
H.R.4348, S.2398, Kay Hagan Tick Act, Issues pertaining to re-authorization, continuation and expansion of support for response to vector born disease. SMASH Act, Issue…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
UNIVERSITY OF WISCONSIN-MADISON · lobbying firm or registrant: LEWIS-BURKE ASSOCIATES, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 10, 2026 · issue area: Budget/Appropriations
$60,000
Paid to lobbying firm
…n and NSF. H.R. 9022, FY 2027 Energy and Water Development Appropriations, Issues pertaining to DOE, Office of Science, Fusion Energy Sciences, plant research. H.R. 4348, Kay Hagan Tick Act, Issues pertaining to vector-borne diseases.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing